On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...